PCM
PTX

Potomac Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Potomac Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,900
Closed -$376K – 89
2014
Q3 		$376K Buy
+4,900
New +$386K 0.41% 58

Other funds holding PTX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Potomac Capital Management's PTX Position: Q4 2014 in Review

Potomac Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2014, closing a stake of 4,900 shares — an estimated $376K sold.

Potomac Capital Management first reported a position in PTX in Q3 2014 and held it in 1 quarter. The position peaked at $376K in Q3 2014. 97 funds tracked by Wall St. Rank hold PTX as of Q4 2014.

  • Potomac Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2014 after selling out during the quarter.
  • Potomac Capital Management sold 4,900 Pernix Therapeutics Holdings, Inc. shares in Q4 2014, an estimated $376K.
  • Potomac Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2014 and held it in 1 quarter.
  • Potomac Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $376K in Q3 2014.
  • 97 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2014.

Based on Potomac Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.